期刊文献+

Research progresses in the pathogenesis of anaplastic largecell lymphoma

Research progresses in the pathogenesis of anaplastic largecell lymphoma
下载PDF
导出
摘要 Anaplastic large cell lymphoma(ALCL) is a distinct subset of T-cell non-Hodgkin's lymphoma.As a consequence of its low incidence,general pathogenic consideration of ALCL is lacking.In this review,we summarize the pathogenesis,epidemiology,clinical manifestations,and treatment of ALCL,so as to better understand key stages of the development of this disease and provide valuable information for future treatment. Anaplastic large cell lymphoma (ALCL) is a distinct subset of 3--cell non-Hodgkin's lymphoma. As a consequence of its low incidence, general pathogenic consideration of ALCL is lacking. In this review, we summarize the pathogenesis, epidemiology, clinical manifestations, and treatment of ALCL, so as to better understand key stages of the development of this disease and provide valuable information for future treatment.
出处 《Chinese Journal of Cancer》 SCIE CAS CSCD 北大核心 2011年第6期392-399,共8页
基金 supported by Jiangsu Provincial Health Office Grant(No.RC2007072) Jiangsu Provincial Personnel Department Grant(No.07-B-019) Municipal Science and Technology Grant of International Cooperation(No.SWH0815) Application of Basic Science and Technology Grant(No.YJS0912)
关键词 淋巴瘤 发病机制 细胞 变性 发病机理 流行病学 临床表现 发病率 Anaplastic large cell lymphoma, anaplastic lymphoma kinase, pathogenesis
  • 相关文献

参考文献1

二级参考文献24

  • 1李金范,李甘地,刘卫平,王影,程继荣,陈宇,杨红,汤合莲,白燕琼,林德广,杜丽惠,彭凤翔,杨永红,赵春.间变性大细胞淋巴瘤组织间变性淋巴瘤激酶及survivin蛋白表达及其临床意义[J].中华病理学杂志,2006,35(4):213-217. 被引量:18
  • 2Medeiros LJ, Elenitoba-Johnson KS. Anaplastic large cell lymphoma [J]. Am J Clin Pathol, 2007,127(5):707-722.
  • 3Jaffe ES, Harris NL, Stein H, et al. World Health Organization Classification of Tumors: pathology and genetics of tumors of haematopoietic and lymphoid tissues [M]. Lyon, France: IARC Press, 2001:230-235.
  • 4Cheson BD, Homing S J, Coiffier B, et al. Report on an international workshop to standardize response criteria for non- Hodgkin's lyrnphomas. NCI Sponsored International Working Group [J]. J Clin Oneol, 1999, 17(4): 1244-1253.
  • 5Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells [J]. Blood, 1985,66(4):848-858.
  • 6Stein H, Foss HD, Durkop H, et al. CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features [J]. Blood, 2000,96(12) :3681-3695.
  • 7Falini B. Anaplastic large cell lymphoma: pathological, molecular and clinical features[J]. Br J Haematol, 2001,114 (4) :741-760.
  • 8Park SR, Baek JY, Kim DW, et al. Primary systemic anaplastic large cell lymphoma in a single Korean institution: clinical characteristics and treatment outcome [J]. J Korean Med Sol, 2006,21(4) :633-638.
  • 9Falini B, Pileri S, Zinzani PL, et al. ALK+ lymphoma: clinicopathological findings and outcome [J]. Blood, 1999,93(8): 2697-2706.
  • 10Kadin ME, Carpenter C. Systemic and primary cutaneous anaplastic large cell lymphomas [J]. Semin Hematol, 2003,40 (3):244-256.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部